Fidia S.p.A. (BIT:FDA)
Italy · Delayed Price · Currency is EUR 0.1160
-0.0003 (-0.26%)
At close: Jan 30, 2026
Fidia Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 21.08 | 17.49 | 28.61 | 24.37 | 23.84 | 21.24 |
Other Revenue | 0.05 | 0.05 | 0.13 | 0.3 | 0.34 | 0.42 |
| 21.13 | 17.53 | 28.74 | 24.66 | 24.18 | 21.65 | |
Revenue Growth (YoY) | -28.94% | -38.98% | 16.52% | 2.01% | 11.65% | -53.13% |
Cost of Revenue | 6.4 | 4.52 | 9.48 | 9.58 | 8.31 | 7.55 |
Gross Profit | 14.73 | 13.02 | 19.26 | 15.09 | 15.87 | 14.1 |
Selling, General & Admin | 10.53 | 10.91 | 11.32 | 10.91 | 10.58 | 11.31 |
Other Operating Expenses | 7.74 | 6.99 | 8.21 | 6.9 | 5.07 | 5.34 |
Operating Expenses | 19.65 | 19.33 | 20.96 | 19.71 | 17.64 | 19.56 |
Operating Income | -4.92 | -6.32 | -1.7 | -4.62 | -1.77 | -5.46 |
Interest Expense | -0.36 | -0.4 | -0.42 | -0.34 | -0.33 | -0.45 |
Interest & Investment Income | 0.05 | 0.07 | 0.07 | 0.02 | 0.02 | 0.03 |
Currency Exchange Gain (Loss) | 0.07 | -0.31 | 0.01 | 0.07 | -0.34 | 0.21 |
Other Non Operating Income (Expenses) | 3.06 | -1.94 | 0.82 | -0.01 | -0.05 | -0.09 |
EBT Excluding Unusual Items | -2.09 | -8.89 | -1.23 | -4.88 | -2.47 | -5.76 |
Gain (Loss) on Sale of Assets | 0.79 | 0.05 | 0.01 | 0.05 | 0.03 | 0.26 |
Asset Writedown | -0.21 | -0.21 | - | -0.4 | -0.01 | -0.65 |
Other Unusual Items | -0.4 | -0.21 | -0.01 | 10.77 | -1.03 | 0.09 |
Pretax Income | -1.87 | -9.18 | -1.23 | 5.55 | -3.26 | -6.04 |
Income Tax Expense | 0.54 | 0.31 | 0.25 | -0.21 | 0.24 | -0.09 |
Earnings From Continuing Operations | -2.4 | -9.5 | -1.47 | 5.75 | -3.5 | -5.95 |
Minority Interest in Earnings | 0.21 | 0.2 | 0.17 | 0.21 | 0.29 | 0.24 |
Net Income | -2.19 | -9.3 | -1.31 | 5.97 | -3.2 | -5.71 |
Net Income to Common | -2.19 | -9.3 | -1.31 | 5.97 | -3.2 | -5.71 |
Shares Outstanding (Basic) | 2 | 0 | 0 | 0 | 0 | 0 |
Shares Outstanding (Diluted) | 2 | 0 | 0 | 0 | 0 | 0 |
Shares Change (YoY) | 1197.67% | 308.31% | - | 35.58% | - | - |
EPS (Basic) | -1.15 | -32.85 | -18.85 | 86.08 | -62.62 | -111.64 |
EPS (Diluted) | -1.15 | -32.85 | -18.90 | 86.08 | -62.62 | -111.64 |
Free Cash Flow | -4.96 | -4.45 | -4.88 | 0.7 | 0.55 | 3.59 |
Free Cash Flow Per Share | -2.59 | -15.71 | -70.41 | 10.08 | 10.84 | 70.11 |
Gross Margin | 69.71% | 74.24% | 67.03% | 61.18% | 65.64% | 65.11% |
Operating Margin | -23.27% | -36.02% | -5.93% | -18.75% | -7.32% | -25.21% |
Profit Margin | -10.37% | -53.03% | -4.55% | 24.20% | -13.24% | -26.36% |
Free Cash Flow Margin | -23.46% | -25.37% | -16.99% | 2.83% | 2.29% | 16.56% |
EBITDA | -4.86 | -6.07 | -1.43 | -4.25 | -1.43 | -5.02 |
EBITDA Margin | -23.01% | -34.63% | -4.97% | -17.22% | -5.91% | -23.16% |
D&A For EBITDA | 0.05 | 0.24 | 0.27 | 0.38 | 0.34 | 0.45 |
EBIT | -4.92 | -6.32 | -1.7 | -4.62 | -1.77 | -5.46 |
EBIT Margin | -23.27% | -36.02% | -5.93% | -18.75% | -7.32% | -25.21% |
Revenue as Reported | 23.39 | 19.06 | 29.94 | 25.85 | 25.28 | 23.36 |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.